Brazil's locally produced efavirenz released
This article was originally published in Scrip
Executive Summary
Brazil's health ministry has received the first locally produced batch of the antiretroviral efavirenz after the country issued a compulsory licence for Merck & Co's Stocrin in 2007. The move has proved successful, without deterring investment in Brazil's pharma industry as many had feared, says the ministry.